BeStock  
Stocks › Medical Devices › TMDX

TransMedics TMDX

US equityMarket cap rank #2438Medical Devices
$85.25 −$8.77 (-9.33%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $85.60 +0.41%
Open$90.81
Prev close$94.02
Day range$83.89 – $91.62
Volume1.59M
Market cap$2.96B
P/E (TTM)23.2
Dividend yield–

Fundamentals

Latest reported quarter: Q3, ended Sep 2026

Revenue$203.01M+41.1% YoY
Operating profit$28.14M+20.8% YoY
Net profit$17.07M-29.8% YoY
Diluted EPS$0.46-30.3% YoY
Free cash flow$27.60M-55.4% YoY
Operating cash flow$36.00M

Revenue, last 8 quarters

$121.6MDec '24$143.5MMar '25$157.4MJun '25$143.8MSep '25$160.8MDec '25$173.9MMar '26$189.9MJun '26$203.0MSep '26

Net profit, last 8 quarters

$6.9MDec '24$25.7MMar '25$34.9MJun '25$24.3MSep '25$105.4MDec '25$7.3MMar '26$14.7MJun '26$17.1MSep '26

Diluted EPS by quarter

0.19Dec '240.70Mar '250.92Jun '250.66Sep '252.62Dec '250.20Mar '260.41Jun '260.46Sep '26

Free cash flow by quarter

$6.1MDec '24$-29.9MMar '25$82.5MJun '25$61.9MSep '25$19.0MDec '25$-12.1MMar '26$10.2MJun '26$27.6MSep '26

Annual revenue

$25.6MFY20$30.3MFY21$93.5MFY22$241.6MFY23$441.5MFY24$605.5MFY25

Profitability & balance sheet

Gross margin58.6%
Operating margin11.9%
Net margin19.9%
Return on equity31.9%
Return on assets11.7%
Return on invested capital13.9%
Current ratio4.53
Liabilities / assets63.7%
Cash & investments$492.96M
Total debt$863.26M
Net cash (debt)-$370.30M
Free cash flow / sales6.1%

Where the revenue comes from

Quarter 2026/Q3

By business line

  • Liver revenue$150.44M 74.1%
  • Heart revenue$38.60M 19.0%
  • Service revenue unrelated to Organ Care System (OCS) transplant$10.50M 5.2%
  • Lung revenue$3.08M 1.5%
  • Other transplant-related revenue$437,000.00 0.2%

Income statement

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Revenue as Reported $203.01M $189.95M $173.93M $605.49M $160.76M
Total Operating Revenue $203.01M $189.95M $173.93M $605.49M $160.76M
Cost of Revenue $84.35M $76.75M $72.77M $242.69M $67.35M
Gross Profit $118.66M $113.20M $101.16M $362.81M $93.41M
Operating Expense $90.52M $89.46M $87.86M $254.22M $72.14M
Selling and Admin Expenses $56.77M $53.54M $56.92M $185.17M $55.96M
-Selling & Marketing Expense $210,000.00 $1.72M $1.27M $4.32M $1.27M
-General & Admin Expense $56.56M $51.82M $55.65M $180.85M $54.69M
Research & Development $29.18M $31.63M $24.88M $69.06M $20.70M
Depreciation & Amortization & Depletion $4.56M $4.29M $6.06M – –
-Depreciation & Amortization $4.56M $4.29M $6.06M – –
Operating Profit $28.14M $23.74M $13.30M $108.58M $21.27M
Net Non-Operating Interest Income (Expense) -$7.27M -$4.23M -$7.17M -$13.78M -$3.35M
Non-Operating Interest Expense $7.27M $7.23M $7.17M $13.78M $3.35M
Other Income (Expense) $3.23M -$100,000.00 $2.36M $12.72M $3.71M
Other Non-Operating Income (Expenses) $3.23M – $2.36M $12.72M $3.71M
Pretax Profit $24.10M $19.41M $8.49M $107.52M $21.63M
Tax $7.03M $4.72M $1.17M -$82.77M -$83.75M
Net Profit $17.07M $14.68M $7.32M $190.29M $105.38M
Profit from Continuing Operations $17.07M $14.68M $7.32M $190.29M $105.38M
Net Income to Parent Company $17.07M $14.68M $7.32M $190.29M $105.38M
Net Income to Common Stockholders $17.07M $14.68M $7.32M $190.29M $105.38M
Basic EPS $0.49 $0.42 $0.21 $5.60 $3.08
Diluted EPS $0.46 $0.41 $0.20 $4.87 $2.62
Non-Operating Interest Income – $3.00M – – –
Gain on Sale of Security – -$100,000.00 – – –

Balance sheet

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Total Assets $1.52B $1.46B $1.43B $1.07B $1.07B
Total Current Assets $692.46M $651.12M $619.28M $637.78M $637.78M
Cash and Cash Equivalents & Short-Term Investments $492.96M $472.68M $461.74M $488.37M $488.37M
-Cash and Cash Equivalents $492.96M $472.68M $461.74M $488.37M $488.37M
Receivables $114.94M $104.14M $90.73M $84.28M $84.28M
-Accounts Receivable $114.94M $104.14M $90.73M $84.28M $84.28M
Inventory $58.37M $54.14M $49.89M $48.88M $48.88M
Other Current Assets $26.19M $20.17M $16.92M $16.25M $16.25M
Total Non-Current Assets $825.48M $813.27M $815.54M $430.59M $430.59M
Net PPE $711.23M $702.42M $700.97M $332.81M $332.81M
-Gross PPE $801.82M $784.38M $774.80M $398.88M $398.88M
-Accumulated Depreciation -$90.59M -$81.96M -$73.82M -$66.07M -$66.07M
Goodwill and Other Intangible Assets $20.83M $11.55M $11.55M $13.50M $13.50M
-Goodwill $18.02M $11.55M $11.55M $11.55M $11.55M
-Other Intangible Assets $2.82M – – $1.95M $1.95M
Non-Current Deferred Assets $72.79M $78.68M $82.48M $83.54M $83.54M
Other Non-Current Assets $20.63M $20.63M $20.54M $739,000.00 $739,000.00
Total Liabilities $967.23M $946.34M $940.81M $595.27M $595.27M
Total Current Liabilities $152.86M $98.28M $91.92M $89.31M $89.31M
Payables $10.14M $12.91M $11.15M $10.35M $10.35M
-Accounts Payable $10.14M $12.91M $11.15M $10.35M $10.35M
Current Accrued Expenses $82.76M $58.60M $59.32M $62.74M $62.74M
Short-Term Debt and Capital Lease Obligation $58.46M $23.65M $18.51M $13.31M $13.31M
-Current Debt $54.82M $20.00M $15.00M $10.00M $10.00M
-Current Capital Lease Obligation $3.64M $3.65M $3.51M $3.31M $3.31M
Current Deferred Liabilities $1.50M $3.13M $2.95M $2.91M $2.91M
Total Non-Current Liabilities $814.37M $848.06M $848.89M $505.97M $505.97M
Long Term Debt and Capital Lease Obligation $808.44M $844.07M $844.91M $505.97M $505.97M
-Long Term Debt $454.99M $494.00M $498.20M $502.39M $502.39M
-Long Term Capital Lease Obligation $353.45M $350.07M $346.71M $3.58M $3.58M
Other Non-Current Liabilities $5.93M $3.99M $3.99M – –
Total Equity $550.71M $518.05M $494.01M $473.10M $473.10M
Stockholders' Equity $550.71M $518.05M $494.01M $473.10M $473.10M
Capital Stock $789.90M $774.22M $764.64M $750.93M $750.93M
-Common Stock $789.90M $774.22M $764.64M $750.93M $750.93M
-Preferred Stock $0.00 $0.00 $0.00 $0.00 $0.00
Retained Earnings -$238.88M -$255.95M -$270.64M -$277.95M -$277.95M
Gains/Losses Not Affecting Retained Earnings -$306,000.00 -$210,000.00 $2,000.00 $124,000.00 $124,000.00

Cash flow

Line item 2026 Q3 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4
Operating Cash Flow $36.00M $17.31M $24.53M $192.84M $34.51M
Net cash flow from continuing operations $36.00M $17.31M $24.53M $192.84M $34.51M
Net Income from Continuing Operations $17.07M $14.68M $7.32M $190.29M $105.38M
Gain/Loss from Continuing Operations $258,000.00 $166,000.00 $486,000.00 -$1.54M -$141,000.00
Depreciation & Depletion & Amortization $10.84M $10.24M $11.86M $27.19M $7.47M
Deferred Tax $5.89M $3.80M $1.07M -$83.54M -$83.54M
Other Non-Cash Items $5.40M $5.26M $5.20M $5.21M $1.29M
Change in Working Capital -$16.05M -$25.44M -$11.35M $18.38M -$5.34M
-Change in Receivables -$8.12M -$13.43M -$6.52M $13.95M -$3.58M
-Change in Inventory -$9.11M -$6.35M -$3.90M -$7.72M -$6.53M
-Change in Prepaid Assets -$4.56M -$4.35M $1.96M -$3.76M $1.06M
-Change in Payables and Accrued Expense $8.25M -$632,000.00 -$1.98M $17.68M $4.90M
-Change in Other Current Assets $9,000.00 -$87,000.00 -$155,000.00 -$23,000.00 -$13,000.00
-Change in Other Current Liabilities -$888,000.00 -$783,000.00 -$805,000.00 -$2.90M -$777,000.00
-Change In Other Working Capital -$1.63M $185,000.00 $40,000.00 $1.14M -$399,000.00
Net cash flow from investing -$13.71M -$7.09M -$36.66M -$59.25M -$15.51M
Net Cash Flow from Continuing Investing Activities -$13.71M -$7.09M -$36.66M -$59.25M -$15.51M
Net PPE Purchase and Sale -$8.40M -$7.09M -$36.66M -$59.25M -$15.51M
Financing Cash Flow -$1.92M $970,000.00 $3.76M $16.86M $3.10M
Net Cash Flow from Continuing Financing Activities -$1.92M $970,000.00 $3.76M $16.86M $3.10M
Proceeds from Stock Option Exercised $3.23M $1.01M $3.90M $17.00M $3.10M
Net Other Financing Charges -$140,000.00 -$39,000.00 -$138,000.00 -$138,000.00 $0.00
Ending Cash Balance $511.40M $491.11M $480.18M $488.87M $488.87M
Net Change in Cash $20.38M $11.19M -$8.36M $150.45M $22.10M
Beginning Cash Balance $491.11M $480.18M $488.87M $337.15M $466.67M
Effect of Exchange Rate Changes -$92,000.00 -$251,000.00 -$327,000.00 $1.27M $94,000.00
Free Cash Flow $27.60M $10.22M -$12.12M $133.59M $19.00M
Net Intangibles Purchase and Sale – – – $0.00 –
Net Business Purchase and Sale – – – $0.00 $0.00
Net Issuance Payments Of Debt – – – $0.00 $0.00

Discussion

No comments yet — be the first to weigh in on TMDX.

Sign in to join the discussion.

Scroll to Top